Skip to main content
. 2016 Nov 4;7(50):83060–83070. doi: 10.18632/oncotarget.13067

Figure 2. Effect of miR-31 on cisplatin sensitivity and invasion capacity of DDP-resistant cells.

Figure 2

A. The affirmation of the level of miR-31 mRNA expressed in GBC-SD/DDP and NOZ/DDP cells transfected with miR-31 mimic by qRT-PCR. B. The cell viability plotted against the concentration of DDP in GBC-SD/DPP and NOZ/DPP cells transfected with miR-31 or vector. C. Colony formation assay of DDP-resistant cells transfected with miR-31 or vector after exposure to DDP. D. The DDP-induced apoptosis rate of GBC-SD/DPP and NOZ/DPP cells transfected with miR-31 or vector analyzed by flow cytometry. E. The invasive ability of DDP-resistant cells transfected with miR-31 or vector after treatment with DDP in the transwell invasion assay. Data were presented as mean ± SD. *P < 0.05; **P < 0.01.